Hypomethylating therapy and autoimmunity in MDS: an enigmatic relationship.
Ioannis
I
Kotsianidis
Emmanouil
E
Spanoudakis
Evangelia
E
Nakou
Paraskevi
P
Miltiades
Dimitrios
D
Margaritis
Costas
C
Tsatalas
Argyrios
A
Tzouvelekis
Anastasia
A
Oikonomou
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001374:Azacitidine / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000188:drug therapy*; D017565:Sarcoidosis, Pulmonary / Q000150:complications* / Q000188:drug therapy
D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine